Literature DB >> 35014184

Viral replication dynamics could critically modulate vaccine effectiveness and should be accounted for when assessing new SARS-CoV-2 variants.

Wan Yang1, Jeffrey Shaman2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35014184      PMCID: PMC8818828          DOI: 10.1111/irv.12961

Source DB:  PubMed          Journal:  Influenza Other Respir Viruses        ISSN: 1750-2640            Impact factor:   4.380


× No keyword cloud information.
  8 in total

1.  Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.

Authors:  Wilfredo F Garcia-Beltran; Evan C Lam; Kerri St Denis; Adam D Nitido; Zeidy H Garcia; Blake M Hauser; Jared Feldman; Maia N Pavlovic; David J Gregory; Mark C Poznansky; Alex Sigal; Aaron G Schmidt; A John Iafrate; Vivek Naranbhai; Alejandro B Balazs
Journal:  Cell       Date:  2021-03-12       Impact factor: 41.582

2.  Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant.

Authors:  Baisheng Li; Aiping Deng; Kuibiao Li; Yao Hu; Zhencui Li; Yaling Shi; Qianling Xiong; Zhe Liu; Qianfang Guo; Lirong Zou; Huan Zhang; Meng Zhang; Fangzhu Ouyang; Juan Su; Wenzhe Su; Jing Xu; Huifang Lin; Jing Sun; Jinju Peng; Huiming Jiang; Pingping Zhou; Ting Hu; Min Luo; Yingtao Zhang; Huanying Zheng; Jianpeng Xiao; Tao Liu; Mingkai Tan; Rongfei Che; Hanri Zeng; Zhonghua Zheng; Yushi Huang; Jianxiang Yu; Lina Yi; Jie Wu; Jingdiao Chen; Haojie Zhong; Xiaoling Deng; Min Kang; Oliver G Pybus; Matthew Hall; Katrina A Lythgoe; Yan Li; Jun Yuan; Jianfeng He; Jing Lu
Journal:  Nat Commun       Date:  2022-01-24       Impact factor: 14.919

3.  Waning Immunity after the BNT162b2 Vaccine in Israel.

Authors:  Yair Goldberg; Micha Mandel; Yinon M Bar-On; Omri Bodenheimer; Laurence Freedman; Eric J Haas; Ron Milo; Sharon Alroy-Preis; Nachman Ash; Amit Huppert
Journal:  N Engl J Med       Date:  2021-10-27       Impact factor: 91.245

4.  Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.

Authors:  Noam Barda; Noa Dagan; Cyrille Cohen; Miguel A Hernán; Marc Lipsitch; Isaac S Kohane; Ben Y Reis; Ran D Balicer
Journal:  Lancet       Date:  2021-10-29       Impact factor: 79.321

5.  Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.

Authors:  Hiam Chemaitelly; Patrick Tang; Mohammad R Hasan; Sawsan AlMukdad; Hadi M Yassine; Fatiha M Benslimane; Hebah A Al Khatib; Peter Coyle; Houssein H Ayoub; Zaina Al Kanaani; Einas Al Kuwari; Andrew Jeremijenko; Anvar H Kaleeckal; Ali N Latif; Riyazuddin M Shaik; Hanan F Abdul Rahim; Gheyath K Nasrallah; Mohamed G Al Kuwari; Hamad E Al Romaihi; Adeel A Butt; Mohamed H Al-Thani; Abdullatif Al Khal; Roberto Bertollini; Laith J Abu-Raddad
Journal:  N Engl J Med       Date:  2021-10-06       Impact factor: 91.245

6.  Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.

Authors:  Emma C Wall; Mary Wu; Ruth Harvey; Gavin Kelly; Scott Warchal; Chelsea Sawyer; Rodney Daniels; Philip Hobson; Emine Hatipoglu; Yenting Ngai; Saira Hussain; Jerome Nicod; Robert Goldstone; Karen Ambrose; Steve Hindmarsh; Rupert Beale; Andrew Riddell; Steve Gamblin; Michael Howell; George Kassiotis; Vincenzo Libri; Bryan Williams; Charles Swanton; Sonia Gandhi; David Lv Bauer
Journal:  Lancet       Date:  2021-06-03       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.